Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital

References

• Lokke A, Fabricius PG, Vestbo J, Marott JL, Lange P. pPrevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study. Ugeskr Laeger 2007; 169: 3956–60
   PubMedGoogle Scholar
• Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627–43
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–52
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD: a 1-y prospective study. Respir Med 2003; 97: 770–7
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418–22
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?. Eur Respir J Suppl 2002; 36: S9–19
   Google Scholar
• Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med 1969; 280: 397–404
   PubMed Web of Science ®Google Scholar
• Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, Rodriguez-Elvira M, Guerrero-Lopez F, Vazquez-Mata G. Six-y mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006; 34: 2317–24
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465–71
   PubMed Web of Science ®Google Scholar
• Ko FW, Ng TK, Li TS, Fok JP, Chan MC, Wu AK, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99: 454–60
   PubMed Web of Science ®Google Scholar
• Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157: 1498–505
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116: 40–6
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1090–5
   PubMed Web of Science ®Google Scholar
• Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, et al. Microbiological determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165: 891–7
   PubMed Web of Science ®Google Scholar
• Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759–64
   PubMed Web of Science ®Google Scholar
• White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease: the aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003; 58: 73–80
   PubMed Web of Science ®Google Scholar
• Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 2003; 58: 37–42
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618–23
   PubMed Web of Science ®Google Scholar
• Nair B, Stapp J, Stapp L, Bugni L, Van DJ, Burns JL. Utility of Gram staining for evaluation of the quality of cystic fibrosis sputum samples. J Clin Microbiol 2002; 40: 2791–4
   PubMed Web of Science ®Google Scholar
• Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2000; 117: 1638–45
   PubMed Web of Science ®Google Scholar
• Monso E, Garcia-Aymerich J, Soler N, Farrero E, Felez MA, Anto JM, et al. Bacterial infection in exacerbated COPD with changes in sputum characteristics. Epidemiol Infect 2003; 131: 799–804
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–89
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177: 19–26
   PubMed Web of Science ®Google Scholar
• Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriological aetiology and lung function. Chest 1998; 113: 1542–8
   PubMed Web of Science ®Google Scholar
• Lieberman D. Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med 2003; 2: 459–68
   PubMedGoogle Scholar
• Hoiby N. New antimicrobials in the management of cystic fibrosis. J Antimicrob Chemother 2002; 49: 235–8
   PubMed Web of Science ®Google Scholar
• Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2006;(2):CD004403.
   Google Scholar
• Brand RA. Local chemotherapy with primary closure of septic wounds by means of drainage and irrigation cannulae: M. N. Smith-Petersen (1886–1953), Carroll B. Larson, Williams Cochran, The 12th President of the AAOS 1943 (MNS-P). Clin Orthop Relat Res 2008; 466: 104–12
   PubMed Web of Science ®Google Scholar